Although weekly infusions over 5 weeks of ETC-216 or ApoA-1 Milano (an HDL mimetic) produced significant regression of coronary atherosclerosis in ACS patients, this study has several limitations.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback